Search research articles
Contact Us
Filters
Showing results (351-360 of 365) with videos related to
Page
of 37
Sort By:
International Journal of Molecular Sciences
|
May 11, 2024
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases
Bo-Shi Zhang, Xiao-Meng Zhang, Masaaki Ito, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2010
Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activity
Lakshman E Rajagopalan, Michael S Davies, Larry E Kahn, et al.
Cancers
|
April 27, 2024
Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan
Marin Ishikawa, Kohei Nakamura, Ryutaro Kawano, et al.
International Journal of Molecular Medicine
|
September 18, 2020
Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
Shu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, et al.
Medicine International
|
July 10, 2024
Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases
Takaki Hiwasa, Yoichi Yoshida, Masaaki Kubota, et al.
Frontiers in Cardiovascular Medicine
|
February 27, 2023
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
Shu-Yang Li, Yoichi Yoshida, Masaaki Kubota, et al.
Ebiomedicine
|
November 8, 2025
Long lasting complement neutralisation by RAY121, an engineered anti-C1s antibody with C1q displacement function
Adrian W S Ho, Taku Fukuzawa, Hikaru Koga, et al.
Nature Communications
|
December 22, 2023
Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease
Yuu Okura, Yuri Ikawa-Teranishi, Akihiko Mizoroki, et al.
Scientific Reports
|
June 30, 2021
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
Shu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, et al.
Cancer Science
|
September 17, 2020
Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
Makoto Sumazaki, Hideaki Shimada, Masaaki Ito, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 365) with videos related to
Sort By:
Page
of 37
International Journal of Molecular Sciences
|
May 11, 2024
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases
Bo-Shi Zhang, Xiao-Meng Zhang, Masaaki Ito, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2010
Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activity
Lakshman E Rajagopalan, Michael S Davies, Larry E Kahn, et al.
Cancers
|
April 27, 2024
Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan
Marin Ishikawa, Kohei Nakamura, Ryutaro Kawano, et al.
International Journal of Molecular Medicine
|
September 18, 2020
Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
Shu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, et al.
Medicine International
|
July 10, 2024
Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases
Takaki Hiwasa, Yoichi Yoshida, Masaaki Kubota, et al.
Frontiers in Cardiovascular Medicine
|
February 27, 2023
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
Shu-Yang Li, Yoichi Yoshida, Masaaki Kubota, et al.
Ebiomedicine
|
November 8, 2025
Long lasting complement neutralisation by RAY121, an engineered anti-C1s antibody with C1q displacement function
Adrian W S Ho, Taku Fukuzawa, Hikaru Koga, et al.
Nature Communications
|
December 22, 2023
Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease
Yuu Okura, Yuri Ikawa-Teranishi, Akihiko Mizoroki, et al.
Scientific Reports
|
June 30, 2021
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
Shu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, et al.
Cancer Science
|
September 17, 2020
Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
Makoto Sumazaki, Hideaki Shimada, Masaaki Ito, et al.
Page
of 37